Neutral lipid storage disease with ichthyosis (Chanarin-Dorfman syndrome): A Patient Guide

Neutral Lipid Storage Disease with Ichthyosis (NLSDI), also known as Chanarin-Dorfman Syndrome (CDS), is an extremely rare genetic condition that changes how your body manages and stores fats. At its core, the condition is caused by pathogenic variants in the ABHD5 gene, which normally acts as a crucial “helper” protein. This protein’s job is to co-activate the machinery that breaks down triglycerides (a type of fat) stored inside your cells. When this gene is mutated, the breakdown process is significantly impaired. As a result, these fats accumulate, forming tiny bubbles called lipid droplets that crowd the inside of various tissues throughout the body ^[1][2].

This buildup of fat affects multiple systems, starting with the skin. In the skin’s outer layer, the ABHD5 protein is also responsible for helping build the oily “mortar” that keeps your skin barrier waterproof and protected. When this process is disrupted, the skin loses moisture too quickly and becomes red and scaly, a condition known as congenital nonbullous ichthyosiform erythroderma (ichthyosis). Beyond the skin, the accumulation of lipid droplets can affect the liver, causing it to become enlarged or fatty (steatosis), and can impact the muscles, eyes, and hearing. Because the symptoms involve so many different parts of the body, the severity and timing of these issues vary considerably from one person to another ^[3][4][5].

Living well with this diagnosis depends on three main pillars of care: early genetic confirmation, protecting the skin barrier, and vigilant monitoring of internal health. Identifying the specific ABHD5 mutation allows your doctors to move past misdiagnoses and focus on a proactive management plan. This plan typically involves a multidisciplinary team—including geneticists, dermatologists, and liver specialists (hepatologists)—who work together to protect your liver and muscles while managing daily skin care. While liver disease is common and can be serious, monitoring priorities depend entirely on the person’s specific symptoms and findings, requiring a tailored schedule for imaging and blood work ^[6][7].

While a diagnosis of such a rare condition—with only a limited number of cases reported worldwide—can feel isolating, it also provides a roadmap for your care. By supporting the skin barrier with daily emollients and working closely with specialists to manage your overall health, you can balance the demands of the condition with your daily life. You are not just managing a skin condition; you are navigating a unique metabolic journey, and having the right team by your side ensures that every part of your health is being watched and protected ^[8][9].